Published in Curr Opin Allergy Clin Immunol on February 01, 2009
Rhinosinusitis diagnosis and management for the clinician: a synopsis of recent consensus guidelines. Mayo Clin Proc (2011) 1.36
Perspectives on the etiology of chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg (2010) 1.20
The effectiveness topical amphotericin B in the management of chronic rhinosinusitis: a meta-analysis. Eur Arch Otorhinolaryngol (2014) 0.75
The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc (1999) 3.79
Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol (2004) 3.49
The diagnosis and management of sinusitis: a practice parameter update. J Allergy Clin Immunol (2005) 1.88
Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial. J Allergy Clin Immunol (2005) 1.84
Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis. J Allergy Clin Immunol (2006) 1.80
Chronic rhinosinusitis: an enhanced immune response to ubiquitous airborne fungi. J Allergy Clin Immunol (2004) 1.52
Summary health statistics for U.S. adults: National Health Interview Survey, 1998. Vital Health Stat 10 (2002) 1.22
BSACI guidelines for the management of rhinosinusitis and nasal polyposis. Clin Exp Allergy (2007) 1.20
Amphotericin B irrigation for the treatment of chronic rhinosinusitis without nasal polyps: a randomized, placebo-controlled, double-blind study. Am J Rhinol (2008) 1.09
Treatment of chronic rhinosinusitis with high-dose oral terbinafine: a double blind, placebo-controlled study. Laryngoscope (2005) 0.96
Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized, double-blind clinical trial. J Allergy Clin Immunol (2004) 0.95
Increased risk of serious pneumococcal disease in patients with asthma. J Allergy Clin Immunol (2008) 2.97
A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. J Allergy Clin Immunol (2008) 2.78
Fungi and allergic lower respiratory tract diseases. J Allergy Clin Immunol (2012) 2.68
IL-33-responsive lineage- CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs. J Immunol (2011) 2.54
School examinations enhance airway inflammation to antigen challenge. Am J Respir Crit Care Med (2002) 2.41
The danger signal, extracellular ATP, is a sensor for an airborne allergen and triggers IL-33 release and innate Th2-type responses. J Immunol (2011) 2.33
Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol (2012) 2.09
Proteases induce production of thymic stromal lymphopoietin by airway epithelial cells through protease-activated receptor-2. J Immunol (2009) 1.96
IL-33-activated dendritic cells induce an atypical TH2-type response. J Allergy Clin Immunol (2009) 1.92
Asthma outcomes: biomarkers. J Allergy Clin Immunol (2012) 1.88
The role of protease activation of inflammation in allergic respiratory diseases. J Allergy Clin Immunol (2004) 1.84
Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial. J Allergy Clin Immunol (2005) 1.84
Intranasal antifungal treatment in 51 patients with chronic rhinosinusitis. J Allergy Clin Immunol (2002) 1.63
Eosinophilic-lymphocytic myocarditis after smallpox vaccination. Lancet (2003) 1.58
Fungal rhinosinusitis: a categorization and definitional schema addressing current controversies. Laryngoscope (2009) 1.54
Chronic rhinosinusitis: an enhanced immune response to ubiquitous airborne fungi. J Allergy Clin Immunol (2004) 1.52
The involvement of glucocorticoids in psychological stress-induced exacerbations of experimental allergic asthma. Int Arch Allergy Immunol (2014) 1.43
Increased numbers of eosinophils, rather than only etiology, predict histologic changes in patients with esophageal eosinophilia. Clin Gastroenterol Hepatol (2012) 1.40
Cigarette smoke-induced oxidative stress suppresses generation of dendritic cell IL-12 and IL-23 through ERK-dependent pathways. J Immunol (2008) 1.29
Striking deposition of toxic eosinophil major basic protein in mucus: implications for chronic rhinosinusitis. J Allergy Clin Immunol (2005) 1.27
Asthma-related environmental fungus, Alternaria, activates dendritic cells and produces potent Th2 adjuvant activity. J Immunol (2009) 1.26
Lineage(-)Sca1+c-Kit(-)CD25+ cells are IL-33-responsive type 2 innate cells in the mouse bone marrow. J Immunol (2011) 1.22
Marked deposition of eosinophil-derived neurotoxin in adult patients with eosinophilic esophagitis. Am J Gastroenterol (2009) 1.21
Marked airway eosinophilia prevents development of airway hyper-responsiveness during an allergic response in IL-5 transgenic mice. J Immunol (2003) 1.17
Increased risk of serious pneumococcal disease in patients with atopic conditions other than asthma. J Allergy Clin Immunol (2010) 1.16
CD38-deficient mice have reduced airway hyperresponsiveness following IL-13 challenge. Am J Physiol Lung Cell Mol Physiol (2006) 1.15
Retracted Dendritic cells activated by cross-linking B7-DC (PD-L2) block inflammatory airway disease. J Allergy Clin Immunol (2005) 1.15
Dynamic role of epithelium-derived cytokines in asthma. Clin Immunol (2012) 1.14
Nonpathogenic, environmental fungi induce activation and degranulation of human eosinophils. J Immunol (2005) 1.12
Intranasal exposure to staphylococcal enterotoxin B elicits an acute systemic inflammatory response. Shock (2006) 1.10
Features of airway remodeling and eosinophilic inflammation in chronic rhinosinusitis: is the histopathology similar to asthma? J Allergy Clin Immunol (2003) 1.09
Childhood asthma and measles vaccine response. Ann Allergy Asthma Immunol (2006) 1.09
Retracted Blockade of allergic airway inflammation following systemic treatment with a B7-dendritic cell (PD-L2) cross-linking human antibody. J Immunol (2004) 1.09
Nicotine and oxidative cigarette smoke constituents induce immune-modulatory and pro-inflammatory dendritic cell responses. Mol Immunol (2008) 1.08
Allergen-specific in vitro cytokine production in adult patients with eosinophilic esophagitis. Dig Dis Sci (2006) 1.07
Role of CD38 in TNF-alpha-induced airway hyperresponsiveness. Am J Physiol Lung Cell Mol Physiol (2007) 1.06
Intranasal exposure to bacterial superantigens induces airway inflammation in HLA class II transgenic mice. Infect Immun (2006) 1.05
Influence of asthma status on serotype-specific pneumococcal antibody levels. Postgrad Med (2010) 1.05
Human eosinophils are activated by cysteine proteases and release inflammatory mediators. J Allergy Clin Immunol (2003) 1.04
CD66b regulates adhesion and activation of human eosinophils. J Immunol (2007) 1.02
Human eosinophils recognize endogenous danger signal crystalline uric acid and produce proinflammatory cytokines mediated by autocrine ATP. J Immunol (2010) 1.02
Regulation of TLR2 expression and function in human airway epithelial cells. J Membr Biol (2009) 1.02
Phase I trial of sirolimus combined with radiation and cisplatin in non-small cell lung cancer. J Thorac Oncol (2007) 1.01
Innate antifungal immunity of human eosinophils mediated by a beta 2 integrin, CD11b. J Immunol (2008) 0.98
Recognition of fungal protease activities induces cellular activation and eosinophil-derived neurotoxin release in human eosinophils. J Immunol (2009) 0.97
Platelet-activating factor stimulates cytoplasmic alkalinization and granule acidification in human eosinophils. J Cell Sci (2004) 0.96
Human eosinophils produce neurotrophins and secrete nerve growth factor on immunologic stimuli. Blood (2002) 0.96
Major basic protein homolog (MBP2): a specific human eosinophil marker. J Immunol (2006) 0.95
Gene transcription changes in asthmatic chronic rhinosinusitis with nasal polyps and comparison to those in atopic dermatitis. PLoS One (2010) 0.94
Increases in airway eosinophilia and a th1 cytokine during the chronic asymptomatic phase of asthma. Respir Med (2010) 0.94
Recent advances in epithelium-derived cytokines (IL-33, IL-25, and thymic stromal lymphopoietin) and allergic inflammation. Curr Opin Allergy Clin Immunol (2015) 0.93
Three-dimensional volumetric computed tomographic scoring as an objective outcome measure for chronic rhinosinusitis: clinical correlations and comparison to Lund-Mackay scoring. Int Forum Allergy Rhinol (2013) 0.93
Detection of fungal organisms in eosinophilic mucin using a fluorescein-labeled chitin-specific binding protein. Otolaryngol Head Neck Surg (2002) 0.91
Secretory IgA induces antigen-independent eosinophil survival and cytokine production without inducing effector functions. J Allergy Clin Immunol (2005) 0.91
Preoperative evaluation of patients with history of allergy to penicillin: comparison of 2 models of practice. Mayo Clin Proc (2008) 0.91
Protein microarray analysis in patients with asthma: elevation of the chemokine PARC/CCL18 in sputum. Chest (2008) 0.90
Regulation of eosinophil membrane depolarization during NADPH oxidase activation. J Cell Sci (2003) 0.90
Transcription of interleukin-25 and extracellular release of the protein is regulated by allergen proteases in airway epithelial cells. Am J Respir Cell Mol Biol (2013) 0.90
Innate immunomodulatory effects of cereal grains through induction of IL-10. J Allergy Clin Immunol (2007) 0.89
Post-translational tyrosine nitration of eosinophil granule toxins mediated by eosinophil peroxidase. J Biol Chem (2008) 0.88
Oxidized low-density lipoprotein activates migration and degranulation of human granulocytes. Am J Respir Cell Mol Biol (2003) 0.88
Alternaria fungus induces the production of GM-CSF, interleukin-6 and interleukin-8 and calcium signaling in human airway epithelium through protease-activated receptor 2. Int Arch Allergy Immunol (2012) 0.88
The role of ubiquitous airborne fungi in chronic rhinosinusitis. Clin Rev Allergy Immunol (2006) 0.88
Airway uric acid is a sensor of inhaled protease allergens and initiates type 2 immune responses in respiratory mucosa. J Immunol (2014) 0.88
Acute exacerbations of chronic rhinosinusitis occur in a distinct seasonal pattern. J Allergy Clin Immunol (2010) 0.87
Dual signaling and effector pathways mediate human eosinophil activation by platelet-activating factor. Int Arch Allergy Immunol (2004) 0.87
Degranulation of human eosinophils induced by Paragonimus westermani-secreted protease. Korean J Parasitol (2005) 0.87
Biological activities of ecalectin: a novel eosinophil-activating factor. J Immunol (2002) 0.87
Platelet-activating factor activates two distinct effector pathways in human eosinophils. J Immunol (2002) 0.86
Peripheral blood eosinophils from patients with allergic asthma contain increased intracellular eosinophil-derived neurotoxin. J Allergy Clin Immunol (2004) 0.85
An 8-year-old boy with hypereosinophilic syndrome. Int Arch Allergy Immunol (2011) 0.85
Cockroach induces inflammatory responses through protease-dependent pathways. Int Arch Allergy Immunol (2011) 0.85
Antigen-specific IgG and IgA, but not IgE, activate the effector functions of eosinophils in the presence of antigen. Int Arch Allergy Immunol (2010) 0.84
ATP release and Ca2+ signalling by human bronchial epithelial cells following Alternaria aeroallergen exposure. J Physiol (2013) 0.84
Extensive fractionation and identification of proteins within nasal lavage fluids from allergic rhinitis and asthmatic chronic rhinosinusitis patients. J Sep Sci (2009) 0.84
Effects of the very late adhesion molecule 4 antagonist WAY103 on human peripheral blood eosinophil vascular cell adhesion molecule 1-dependent functions. J Allergy Clin Immunol (2005) 0.84
Excretory-secretory products secreted by Paragonimus westermani delay the spontaneous cell death of human eosinophils through autocrine production of GM-CSF. Int Arch Allergy Immunol (2003) 0.84
The synthetic chemoattractant peptide WKYMVm induces superoxide production by human eosinophils via the phosphoinositide 3-kinase-mediated activation of ERK1/2. Int Arch Allergy Immunol (2005) 0.84
T-bet expression by dendritic cells is required for the repolarization of allergic airway inflammation. Eur J Immunol (2008) 0.84
Severity of childhood asthma and human leukocyte antigens type. J Asthma (2007) 0.83
The roles of a Th2 cytokine and CC chemokine in children with stable asthma: potential implication in eosinophil degranulation. Pediatr Allergy Immunol (2010) 0.83
Effects of respiratory syncytial virus infection and major basic protein derived from eosinophils in pulmonary alveolar epithelial cells (A549). Cell Biol Int (2011) 0.83
Ovalbumin content of influenza vaccines. J Allergy Clin Immunol (2010) 0.83
Pathogenesis of chronic rhinosinusitis: role of airborne fungi and bacteria. Immunol Allergy Clin North Am (2004) 0.83
Eosinophil degranulation is more important than eosinophilia in identifying asthma in chronic cough. J Asthma (2011) 0.83
Comparison of the effects of repetitive low-dose and single-dose antigen challenge on airway inflammation. J Allergy Clin Immunol (2003) 0.83
Eosinophil granular proteins damage bronchial epithelial cells infected with respiratory syncytial virus. Int Arch Allergy Immunol (2012) 0.82
Human eosinophil innate response to Alternaria fungus through protease-activated receptor-2. Int Arch Allergy Immunol (2011) 0.82
Alternaria inhibits double-stranded RNA-induced cytokine production through Toll-like receptor 3. Int Arch Allergy Immunol (2013) 0.82
Systemic reactions to allergen immunotherapy: a role for measuring a PGD2 metabolite? Ann Allergy Asthma Immunol (2012) 0.82
Spontaneous myocarditis mimicking human disease occurs in the presence of an appropriate MHC and non-MHC background in transgenic mice. J Mol Cell Cardiol (2007) 0.82
Induction of malignant plasma cell proliferation by eosinophils. PLoS One (2013) 0.82
The role of ubiquitous airborne fungi in chronic rhinosinusitis. Curr Allergy Asthma Rep (2005) 0.81
A proposed model to study immunologic changes during chronic rhinosinusitis exacerbations: data from a pilot study. Am J Rhinol Allergy (2013) 0.81
Treatment of asthma with nebulized lidocaine: a randomized, placebo-controlled study. J Allergy Clin Immunol (2004) 0.81
IL-1 family cytokines drive Th2 and Th17 cells to innocuous airborne antigens. Am J Respir Cell Mol Biol (2013) 0.81
A 27 kDa cysteine protease secreted by newly excysted Paragonimus westermani metacercariae induces superoxide anion production and degranulation of human eosinophils. Korean J Parasitol (2008) 0.80
Blood and sputum eosinophil levels in asthma and their relationship to sinus computed tomographic findings. Mayo Clin Proc (2008) 0.80